Malignant Oral Cavity Neoplasm — Trials

Malignant Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

379 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 111
Recruiting: 57
Ph III recruiting: 9
Growth YoY: +11.5%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05069857	Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients	recruiting	Phase 2	46	Shanghai Jiao Tong University School of MedicineOTHER	1	Nov 22, 2023	clinicaltrials
NCT05125055	Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC	recruiting	Phase 2 / Phase 3	80	Shanghai Jiao Tong University School of MedicineOTHER	1	Nov 22, 2023	clinicaltrials